- 英文名称
- Everolimus
- 分子式
- C53H83NO14
- 分子量
- 958.22
- 中文别名
- 依维莫斯; 42-O-(2-羟乙基)纳巴霉素; 42-O-(2-羟乙基)雷帕霉素; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-二羟基-3-((R)-1-((1S,3R,4R)-4-(2-羟基乙氧基)-3-甲氧基环己基)丙-2-基)-10,21-二甲氧基-6,8,12,14,20,26-六甲基-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-十六氢-3H-23,27-环氧吡啶并[21-c][1]氧杂]4]氮杂环hentriacontine-1,5,11,28,29(4H,6H,31H)-五酮; Everolimus(mixture of isomers); CERTICAN; ZORTRESS; AFINITOR; Rapamycin, 42-O-(2-hydroxyethyl)-; RAD-001; SDZRAD; Certica
- 用途
- 生命科学;医药,用于治疗晚期肾细胞癌(已使用舒尼替尼和索拉非尼治疗无效者);预防肾移植和心脏移植术后排斥反应;作为mTOR抑制剂干扰肿瘤细胞生长、分化和代谢,抑制血管生成和葡萄糖摄取。